Physician profile
Amy Van
NPI 1386273431
$1,842.59
in general payments reported to CMS, 2019-2025
10 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $405 · 2022: $935 · 2023: $129 · 2024: $273 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $436.06 | 2022-2024 | Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $422.60 | 2021-2022 | |
| Genzyme Corporation | $301.52 | 2022-2024 | |
| Inari Medical, INC. | $193.35 | 2021 | |
| Insmed, INC. | $118.65 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $109.00 | 2022 | |
| United Therapeutics Corporation | $104.93 | 2024 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.32 | 2025 | Ofev |
| Vapotherm INC | $27.90 | 2022 | |
| Emd Serono, INC. | $27.26 | 2023 | Mavenclad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.